Latest Scheme Of Arrangement News

Washington H. Soul Pattinson and Brickworks Limited have agreed to merge, creating a $14 billion ASX-listed entity that promises greater scale, liquidity, and diversification for shareholders.

NinjaOne has completed its acquisition of Dropsuite, paying shareholders $5.90 per share and installing a new board as the company prepares to delist from the ASX.

Aston Minerals Limited shares will be suspended from trading following court approval of its acquisition by Torque Metals Limited. This marks a significant step in the consolidation of mining assets in Western Australia.

The court has approved the merger scheme between Aston Minerals and Torque Metals, making it legally effective and suspending Aston’s trading. Shareholders will soon receive Torque shares in exchange for their Aston holdings.

Aston Minerals and Torque Metals have secured court approval for their merger schemes, setting the stage for a significant consolidation in the mining sector. Trading of Aston Minerals shares will be suspended from May 29 as the merger moves toward implementation.

MAC Copper Limited has entered a binding agreement for acquisition by Harmony Gold, offering shareholders a compelling 32% premium and signalling a major consolidation in the copper mining sector.

The Australian Competition and Consumer Commission has resumed its review of DP World Australia's proposed acquisition of Silk Logistics, setting a new decision deadline that extends beyond key transaction milestones.

Shareholders of Aston Minerals and Torque Metals have overwhelmingly approved the proposed merger schemes, setting the stage for final court approval and implementation in June 2025.

Aston Minerals Limited held crucial shareholder and optionholder meetings to approve its merger with Torque Metals Limited, marking a significant step toward consolidation in the minerals exploration sector.

Mayne Pharma has clarified why it did not disclose an FDA Untitled Letter to the market despite sharing it with its scheme bidder, reaffirming compliance with ASX rules amid recent share price volatility.

New World Resources Limited has entered a binding agreement for acquisition by Central Asia Metals Plc at a significant premium, valuing the company at approximately A$185 million. The transaction, unanimously recommended by New World’s board, is set to complete by September 2025, subject to shareholder and court approvals.

Mayne Pharma has firmly rejected Cosette Pharmaceuticals’ assertion of a Material Adverse Change that could derail their acquisition scheme, insisting the deal process continues as planned.